FIELD: biotechnology.
SUBSTANCE: population of recombinant bacteria is proposed for treating and/or alleviating a disease selected from an inflamed wound and tumour, a recombinant nucleic acid for obtaining the specified population of recombinant bacteria, a pharmaceutical composition for treating and/or facilitating wound healing containing an effective amount of the specified population of recombinant bacteria, a kit for treating and/or alleviating a disease selected from an inflamed wound and tumour, containing the specified population of recombinant bacteria, a medical device for treating and/or alleviating a disease selected from the inflamed wound and tumour, containing the specified population of recombinant bacteria.
EFFECT: invention provides effective treatment and/or alleviation of a disease selected from an inflamed wound and a tumour.
28 cl, 29 dwg, 8 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODIFIED GRAM-POSITIVE BACTERIA AND THEIR APPLICATIONS | 2012 |
|
RU2773435C2 |
| ISOLATED MODIFIED VP1 CAPSID PROTEIN OF ADENO-ASSOCIATED VIRUS OF SEROTYPE 5 (AAV5), CAPSID AND VECTOR BASED ON IT | 2019 |
|
RU2751592C2 |
| COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF LACTATE FROM C1-COMPOUNDS USING TRANSFORMANTS OF LACTATE DEHYDROGENASE | 2014 |
|
RU2710714C2 |
| HERPES VIRUS WITH A MODIFIED SPECTRUM OF TARGETS CONTAINING HYBRID GLYCOPROTEIN H | 2016 |
|
RU2732120C2 |
| ISOLATED MODIFIED VPI CAPSID PROTEIN OF ADENO-ASSOCIATED VIRUS OF SEROTYPE 9 (AAV9), CAPSID AND VECTOR BASED THEREON | 2021 |
|
RU2825667C2 |
| NEW LIVER TARGETING ADENO-ASSOCIATED VIRAL VECTORS | 2019 |
|
RU2793735C2 |
| SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 |
|
RU2811991C2 |
| AAV VECTORS AIMED AT THE CENTRAL NERVOUS SYSTEM | 2015 |
|
RU2727015C2 |
| RECOVERED NUCLEIC ACID WHICH CODES FVIII-BDD-BASED FUSION PROTEIN AND HETEROLOGOUS SIGNAL PEPTIDE, AND USE THEREOF | 2022 |
|
RU2818229C2 |
| RECOMBINANT YEAST CELLS PRODUCING POLYLACTIC ACID AND THEIR USE | 2016 |
|
RU2758138C2 |
